相似文献
1
Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.
J Neurol Neurosurg Psychiatry. 1980 Nov;43(11):978-85. doi: 10.1136/jnnp.43.11.978.
2
Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
Muscle Nerve. 1980 Mar-Apr;3(2):112-9. doi: 10.1002/mus.880030203.
3
Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission.
Neurology. 1981 Mar;31(3):265-71. doi: 10.1212/wnl.31.3.265.
4
Eaton-Lambert syndrome: electrophysiological normalization during chemotherapy.
Clin Neurol Neurosurg. 1979;81(4):235-40. doi: 10.1016/0303-8467(79)90027-1.
5
Novel drug of choice in Eaton-Lambert syndrome.
J Neurol Neurosurg Psychiatry. 1983 Jul;46(7):684-5. doi: 10.1136/jnnp.46.7.684.
6
Remission of the Lambert-Eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy.
Cancer. 1980 Sep 1;46(5):1123-7. doi: 10.1002/1097-0142(19800901)46:5<1123::aid-cncr2820460508>3.0.co;2-l.
7
4-aminopyridine-a review.
Anaesth Intensive Care. 1982 May;10(2):120-6. doi: 10.1177/0310057X8201000205.
8
A neuromuscular transmission block produced by a cancer tissue extract derived from a patient with the myasthenic syndrome.
Neurology. 1977 Feb;27(2):140-3. doi: 10.1212/wnl.27.2.141.
9
Lambert-Eaton myasthenic syndrome with prominent postexercise exhaustion.
Muscle Nerve. 1993 Jul;16(7):716-9. doi: 10.1002/mus.880160705.
10
The Lambert-Eaton myasthenic syndrome. A review of 50 cases.
Brain. 1988 Jun;111 ( Pt 3):577-96. doi: 10.1093/brain/111.3.577.
引用本文的文献
1
Electrophysiological study in neuromuscular junction disorders.
Ann Indian Acad Neurol. 2013 Jan;16(1):34-41. doi: 10.4103/0972-2327.107690.
2
Improvement in neuromuscular transmission in myasthenia gravis by 3,4-diaminopyridine.
Eur Arch Psychiatry Neurol Sci. 1985;234(6):374-7. doi: 10.1007/BF00386054.
本文引用的文献
1
A study of some electrophysiological properties of human intercostal muscle.
J Physiol. 1960 Dec;154(3):602-7. doi: 10.1113/jphysiol.1960.sp006599.
2
Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors.
J Am Med Assoc. 1957 Mar 30;163(13):1117-24. doi: 10.1001/jama.1957.02970480021005.
3
The quantal components of the mammalian end-plate potential.
J Physiol. 1956 Sep 27;133(3):571-87. doi: 10.1113/jphysiol.1956.sp005610.
4
A further study of the statistical composition on the end-plate potential.
J Physiol. 1955 Oct 28;130(1):114-22. doi: 10.1113/jphysiol.1955.sp005397.
5
Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
Muscle Nerve. 1980 Mar-Apr;3(2):112-9. doi: 10.1002/mus.880030203.
6
Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
Muscle Nerve. 1980 Mar-Apr;3(2):105-11. doi: 10.1002/mus.880030202.
7
The nature of the defect in the Eaton-Lambert syndrome.
Neurology. 1967 Jun;17(6):527-36. doi: 10.1212/wnl.17.6.527.
8
A quantitative study of end-plate potentials in isolated human muscle.
J Physiol. 1965 Jun;178(3):505-29. doi: 10.1113/jphysiol.1965.sp007639.
9
Defects of neuromuscular transmission in syndromes other than myasthenia gravis.
Ann N Y Acad Sci. 1966 Jan 26;135(1):367-84. doi: 10.1111/j.1749-6632.1966.tb45484.x.
10
The administration of guanidine in amyotrophic lateral sclerosis.
Neurology. 1974 Aug;24(8):721-8. doi: 10.1212/wnl.24.8.721.
Zotero 插件